Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2010
11/17/2010CN101886068A Immobilized SUMO system and immobilized SUMO removal system
11/17/2010CN101885778A HPV (Human Papilloma Virus) 16 type L2N120E7E6 fusion protein, gene, preparation method and application
11/17/2010CN101885758A Auto-antigen epitope and encoding gene and application thereof
11/17/2010CN101884783A Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof
11/17/2010CN101884782A Application of bifidobacterium longum adherence inhibition protein Aip for preventing and treating diarrhea
11/17/2010CN101565714B Carbon resource-dependent genetic transformation system for trichoderma reesei and use thereof
11/16/2010US7834258 Dimer of chimeric recombinant binding domain-functional group fusion formed via disulfide-bond-bridge and the processes for producing the same
11/16/2010US7834237 Membrane-localisable fusion protein of an aggregating portion induced through conformational polymerisation
11/16/2010US7834166 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
11/16/2010US7834161 Process for proteolytic cleavage and purification of recombinant proteins produced in plants
11/16/2010US7834159 Pharmacokinetics; glycosyltransferases; vaccines
11/16/2010US7834156 Monoclonal antibody comprising cytotoxic fusion for use in treatment of cell proliferative disorers
11/16/2010US7834155 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope
11/16/2010US7834154 Angiogenesis inhibition
11/16/2010US7833988 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents
11/16/2010US7833786 Anti-IL-6 antibodies, compositions, methods and uses
11/16/2010US7833773 Bacillus mHKcel cellulase
11/16/2010US7833771 Polypeptides having alpha-amylase activity and polynucleotides encoding same
11/16/2010US7833769 McrA variants and uses thereof
11/16/2010US7833768 Polypeptides having phytase activity
11/16/2010US7833759 Method of increasing complementarity in a heteroduplex
11/16/2010US7833754 nucleic acids improved for the expression of interleukin-12 (IL-12); improved cytokine expression in mammalian cells by optimizing all steps of gene expression of the cytokine
11/16/2010US7833753 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally
11/16/2010US7833752 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides
11/16/2010US7833749 used as a reporter gene for cellular systems in combination with bioluminescent or chemoluminescent systems; for energy transfer systems
11/16/2010US7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
11/16/2010US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development
11/16/2010US7833529 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting transmembrane activator and CAML-interactor (TACI)//BCMA ; autoimmune disease; inflammation
11/16/2010US7833528 Drug delivery where chemotherapeutic drug is converted to an active drug by a target-tissue-localized complex that comprises an enzyme formed by premixing bispecific monoclonal antibody or bispecific antibody fragment with a hapten-enzyme covalent conjugate
11/16/2010US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon
11/16/2010US7833520 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
11/16/2010US7832626 Anonymous competition entry
11/16/2010CA2523216C Recombinant alphavirus vectors
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2352073C F0f1-atpase and dna encoding the same
11/16/2010CA2311648C Ifnar2/ifn complex
11/16/2010CA2283462C Vectors having enhanced expression and methods of making and uses thereof
11/16/2010CA2278151C Heregulin variants
11/16/2010CA2197804C Method for the production of recombinant proteins, plasmids and modified cells
11/15/2010CA2704505A1 Method and system for protein purification
11/11/2010WO2010129917A2 Anti-cd100 antibodies and methods for using the same
11/11/2010WO2010129724A2 Efficient biomass fractionating system for an energy pulse crop
11/11/2010WO2010129469A1 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
11/11/2010WO2010129304A2 Method for making heteromultimeric molecules
11/11/2010WO2010128657A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
11/11/2010WO2010128084A1 Probiotic microorganisms isolated from donkey milk
11/11/2010WO2010127492A1 Recombinant bcg vaccine rbcg::xb
11/11/2010WO2010127444A1 Increasing protein production b\ increasing abc50 expression or activity
11/11/2010WO2010075541A3 System for production of ethanol and co-products
11/11/2010WO2007133835A8 Ras mutation and compositions and methods related thereto
11/11/2010US20100287670 Protein expression system
11/11/2010US20100287637 Methods of blocking tissue destruction by autoreactive t cells
11/11/2010US20100287632 Rapid Production of Monoclonal Antibodies
11/11/2010US20100287630 Models for vaccine assessment
11/11/2010US20100287629 Transgenic Non-Human Animals For Producing Chimeric Antibodies
11/11/2010US20100286381 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
11/11/2010US20100286375 Carrier molecules
11/11/2010US20100286374 Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
11/11/2010US20100286371 Methods of Activating Clostridial Toxins
11/11/2010US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents
11/11/2010US20100286366 Polypeptide libraries with a predetermined scaffold
11/11/2010US20100286364 Glycosylated glycopeptide antibiotic derivatives
11/11/2010US20100286068 Molecular markers of plant embryogenesis
11/11/2010US20100286067 Glycoconjugation of polypeptides using oligosaccharyltransferases
11/11/2010US20100286034 Uses for aqueous streams containing proteins
11/11/2010US20100285988 Gamma-Secretase Substrates And Methods Of Use
11/11/2010US20100285563 Non-Ribosomal Peptide Synthetases
11/11/2010US20100285533 Culture media additive and process for using it
11/11/2010US20100285532 Production of heterologous proteins or peptides
11/11/2010US20100285531 Therapeutic and Diagnostic Methods and Compositions Targeting 4Ig-B7-H3 and its Counterpart NK Cell Receptor
11/11/2010US20100285530 E.Coli Host Cells with Modified Phos/Psts Periplasmic Phosphate-binding Proteins, and Method of Manufacturing Recombinant Fabs
11/11/2010US20100285529 Feline granulocyte macrophage colony stimulating factor proteins
11/11/2010US20100285528 Method, vector and system for expressing polypeptides
11/11/2010US20100285527 Novel Polypeptide, cDNA Encoding the Same, and Use Thereof
11/11/2010US20100285526 Compositions and Methods for Fusion Protein Separation
11/11/2010US20100285525 Method
11/11/2010US20100285502 Novel aromatic prenyltransferases, nucleic acids encoding same and uses therefor
11/11/2010US20100285449 Human G-Protein Chemokine Receptor (CCR5) HDGNR10
11/11/2010US20100285132 Immunotherapy compositions, method of making and method of use thereof
11/11/2010US20100285104 Compositions and methods for the delivery of oxygen
11/11/2010US20100285070 Polynucleotides of haemophilus parasuis and its use
11/11/2010US20100285048 Use of flagellin in the immunotherapy of yersinia pestis
11/11/2010US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
11/11/2010US20100285027 Antibodies specific for human hepcidin
11/11/2010US20100285017 Matriptase protein and uses thereof
11/11/2010US20100285014 Immunoglobulin fusion proteins
11/11/2010US20100285009 Humanized anti-egfl7 antibodies and methods using same
11/11/2010US20100284971 Modified factor viii and factor ix genes and vectors for gene therapy
11/11/2010US20100284920 Uses of monoclonal antibody 8h9
11/11/2010US20100284916 Antibodies Against Human Cytomegalovirus (HCMV)
11/11/2010CA2761435A1 Increasing protein production by increasing abc50 expression or activity
11/11/2010CA2761141A1 Probiotic microorganisms isolated from donkey milk
11/11/2010CA2760980A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
11/11/2010CA2760890A1 Anti-cd100 antibodies and methods for using the same
11/10/2010EP2248908A1 Probiotic microorganisms isolated from donkey milk
11/10/2010EP2248901A1 Streptogramines and method for preparing same by mutasynthesis
11/10/2010EP2248892A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function
11/10/2010EP2248831A1 Glycosylated antibodies
11/10/2010EP2248826A1 Antibody directed against pcrv